LRRN4 and cancer: These signaling pathways correlated with the malignant phenotype of cancer cells, including proliferation, cell cycle, apoptosis, epithelial-mesenchymal transition and et al. [30, 32, 33], indicating a crucial regulatory role of LRRN4 in carcinogenesis and progression, as our results indicated.